'USE OF A PEPTIDE DERIVED FROM HUMAN PROTEIN NTIMP3 IN THE TERAPY OF DIABETICAL NEGOTIATION'

摘要

The present invention relates to fusion peptides consisting of the peptide fragment corresponding to the N-terminal domain derived from the human TIMP3 protein, both in native and mutated form, bound by the N-terminal end to a highly selective and efficient carrier peptide for transport in renal proximal tubule cells, the medical use thereof, in particular the use thereof in the treatment of diabetic nephropathy, and the compositions comprising them.